MEDIo — Medistim ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK3.22bn
- NOK3.08bn
- NOK526.36m
- 98
- 16
- 12
- 34
Annual cashflow statement for Medistim ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 70.3 | 69.4 | 90.9 | 114 | 135 |
| Depreciation | |||||
| Changes in Working Capital | -7.94 | -18.4 | 13.8 | -23.8 | -45.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 80.4 | 74.1 | 128 | 113 | 113 |
| Capital Expenditures | -13.7 | — | -7.4 | -9.25 | -16.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -10.6 | -4.08 | -11.9 | -13.3 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.7 | -10.6 | -11.5 | -21.1 | -29.7 |
| Financing Cash Flow Items | 2.8 | 1.39 | 7.59 | 5.4 | 6.01 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -46.9 | -58.3 | -59.1 | -70.3 | -84.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.3 | 5.15 | 57.6 | 23.2 | 1.23 |